Company news

Lupin Limited news in 2025

Lupin Limited's news releases, calls and decks from 2025, newest first.

View company

Press Release Dec 29 2025

December 29, 2025

Press Release Dec 18 2025

December 18, 2025

Press Release Dec 17 2025

December 17, 2025

Press Release Dec 16 2025

December 16, 2025

Lupin Limited Press Release Dec 16 2025

December 15, 2025

Press Release Dec 12 2025

December 12, 2025

Press Release Dec 05 2025

December 5, 2025

Press Release Dec 04 2025

December 4, 2025

Press Release Dec 01 2025

December 1, 2025

Lupin Limited Press Release Dec 01 2025

November 30, 2025

Press Release Nov 28 2025

November 28, 2025

Press Release Nov 15 2025

November 15, 2025

Press Release Nov 14 2025

November 14, 2025

Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™

November 14, 2025

Press Release Nov 13 2025

November 13, 2025

Press Release Nov 12 2025

November 12, 2025

Press Release Nov 08 2025

November 8, 2025

Press Release Nov 06 2025

November 6, 2025

Press Release Nov 05 2025

November 5, 2025

Press Release Oct 30 2025

October 30, 2025

Press Release Oct 28 2025

October 28, 2025

Governor Murphy and Local Leaders Attend Ribbon-Cutting Ceremony, Marking the Inauguration of Lupin's New Corporate Offices in Bridgewater

October 28, 2025

Press Release Oct 24 2025

October 24, 2025

Kenox Pharmaceuticals Appoints Dr. Julianne Berry as Vice President of R&D and Manufacturing

October 21, 2025

Press Release Oct 13 2025

October 13, 2025

Lupin Announces Presentation of Phase 1 Data on LNP3693 (STING agonist) at the ESMO Congress 2025

October 13, 2025

Press Release Oct 09 2025

October 9, 2025

Lupin Unveils Strategic Partnership Program to Expand Reach of its Long-Acting Injectable Platform

October 9, 2025

Press Release Oct 08 2025

October 8, 2025

Lupin Announces Plans to Build a New State-of-the-Art Manufacturing Facility in Coral Springs, Florida Extending its Long-Standing Commitment to America's Patients and Healthcare System

October 8, 2025

Press Release Oct 03 2025

October 3, 2025

Press Release Oct 01 2025

October 1, 2025

Press Release Sep 30 2025

September 30, 2025

Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital

September 29, 2025

Press Release Sep 24 2025

September 24, 2025

Press Release Sep 17 2025

September 17, 2025

Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi's Long-Acting Injectable Platform

September 10, 2025

Press Release Sep 03 2025

September 3, 2025

Press Release Aug 20 2025

August 20, 2025

Press Release Aug 12 2025

August 12, 2025

Press Release Aug 11 2025

August 11, 2025

Press Release Aug 05 2025

August 5, 2025

Press Release Jul 24 2025

July 24, 2025

Press Release Jul 17 2025

July 17, 2025

Press Release Jul 16 2025

July 16, 2025

Press Release Jul 09 2025

July 9, 2025

Press Release Jul 04 2025

July 4, 2025

Press Release Jul 01 2025

July 1, 2025

Press Release Jun 26 2025

June 26, 2025

Press Release Jun 25 2025

June 25, 2025

Older news releases →

Decks in 2025